Gastrointestinal Stromal Tumor (GIST) Drug -Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Gastrointestinal Stromal Tumor (GIST) Drug -Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Gastrointestinal Stromal Tumor (GIST) Drug industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Stromal Tumor (GIST) Drug worldwide and market share by regions, with company and product introduction, position in the Gastrointestinal Stromal Tumor (GIST) Drug market
Market status and development trend of Gastrointestinal Stromal Tumor (GIST) Drug by types and applications
Cost and profit status of Gastrointestinal Stromal Tumor (GIST) Drug, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Stromal Tumor (GIST) Drug market as:
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinic
Hospital
Others
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price and Gross Margin):
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gastrointestinal Stromal Tumor (GIST) Drug -Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Gastrointestinal Stromal Tumor (GIST) Drug industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Stromal Tumor (GIST) Drug worldwide and market share by regions, with company and product introduction, position in the Gastrointestinal Stromal Tumor (GIST) Drug market
Market status and development trend of Gastrointestinal Stromal Tumor (GIST) Drug by types and applications
Cost and profit status of Gastrointestinal Stromal Tumor (GIST) Drug, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Stromal Tumor (GIST) Drug market as:
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinic
Hospital
Others
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price and Gross Margin):
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug in This Report
1.2 Commercial Types of Gastrointestinal Stromal Tumor (GIST) Drug
1.2.1 Amcasertib
1.2.2 Anagrelide hydrochloride CR
1.2.3 APG-1351
1.2.4 Binimetinib
1.2.5 Others
1.3 Downstream Application of Gastrointestinal Stromal Tumor (GIST) Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Development History of Gastrointestinal Stromal Tumor (GIST) Drug
1.5 Market Status and Trend of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2023
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017
2.2 Sales Market of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.2.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.2.2 Sales Value of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.3 Production Market of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.4 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2023
2.4.2 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Types
3.2 Sales Value of Gastrointestinal Stromal Tumor (GIST) Drug by Types
3.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
6.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.4 UK Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.5 France Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
6.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.5 India Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
8.1.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
8.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.2 Production Value of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.3 Basic Information of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Ariad Pharmaceuticals, Inc.
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.1.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Ariad Pharmaceuticals, Inc.
12.2 Arog Pharmaceuticals, Inc.
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Arog Pharmaceuticals, Inc.
12.3 Array BioPharma Inc.
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.3.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Array BioPharma Inc.
12.4 Astex Pharmaceuticals, Inc.
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Astex Pharmaceuticals, Inc.
12.5 Blueprint Medicines Corporation
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Blueprint Medicines Corporation
12.6 Boston Biomedical, Inc.
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Boston Biomedical, Inc.
12.7 Calithera Biosciences, Inc.
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.7.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Calithera Biosciences, Inc.
12.8 Chipscreen Biosciences Ltd
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.8.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences Ltd
12.9 Deciphera Pharmaceuticals, LLC
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.9.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Deciphera Pharmaceuticals, LLC
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.10.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
12.11 Horizon Pharma Plc
12.11.1 Company profile
12.11.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.11.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Horizon Pharma Plc
12.12 Immunicum AB
12.12.1 Company profile
12.12.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.12.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Immunicum AB
12.13 Jiangsu Hengrui Medicine Co., Ltd.
12.13.1 Company profile
12.13.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.13.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine Co., Ltd.
12.14 Kolltan Pharmaceuticals, Inc.
12.14.1 Company profile
12.14.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.14.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Kolltan Pharmaceuticals, Inc.
12.15 Natco Pharma Limited
12.15.1 Company profile
12.15.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.15.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Natco Pharma Limited
12.16 Nerviano Medical Sciences S.r.l.
12.17 Novartis AG
12.18 Omeros Corporation
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
13.1 Industry Chain of Gastrointestinal Stromal Tumor (GIST) Drug
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
14.1 Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.2 Raw Materials Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.3 Labor Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.4 Manufacturing Expenses Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug in This Report
1.2 Commercial Types of Gastrointestinal Stromal Tumor (GIST) Drug
1.2.1 Amcasertib
1.2.2 Anagrelide hydrochloride CR
1.2.3 APG-1351
1.2.4 Binimetinib
1.2.5 Others
1.3 Downstream Application of Gastrointestinal Stromal Tumor (GIST) Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Development History of Gastrointestinal Stromal Tumor (GIST) Drug
1.5 Market Status and Trend of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2023
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017
2.2 Sales Market of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.2.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.2.2 Sales Value of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.3 Production Market of Gastrointestinal Stromal Tumor (GIST) Drug by Regions
2.4 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2023
2.4.2 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Types
3.2 Sales Value of Gastrointestinal Stromal Tumor (GIST) Drug by Types
3.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
6.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.4 UK Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.5 France Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
6.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
6.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.5 India Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
8.1.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
8.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
8.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.2 Production Value of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.3 Basic Information of Gastrointestinal Stromal Tumor (GIST) Drug by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Ariad Pharmaceuticals, Inc.
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.1.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Ariad Pharmaceuticals, Inc.
12.2 Arog Pharmaceuticals, Inc.
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Arog Pharmaceuticals, Inc.
12.3 Array BioPharma Inc.
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.3.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Array BioPharma Inc.
12.4 Astex Pharmaceuticals, Inc.
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Astex Pharmaceuticals, Inc.
12.5 Blueprint Medicines Corporation
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Blueprint Medicines Corporation
12.6 Boston Biomedical, Inc.
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Boston Biomedical, Inc.
12.7 Calithera Biosciences, Inc.
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.7.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Calithera Biosciences, Inc.
12.8 Chipscreen Biosciences Ltd
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.8.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences Ltd
12.9 Deciphera Pharmaceuticals, LLC
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.9.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Deciphera Pharmaceuticals, LLC
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.10.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
12.11 Horizon Pharma Plc
12.11.1 Company profile
12.11.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.11.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Horizon Pharma Plc
12.12 Immunicum AB
12.12.1 Company profile
12.12.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.12.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Immunicum AB
12.13 Jiangsu Hengrui Medicine Co., Ltd.
12.13.1 Company profile
12.13.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.13.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine Co., Ltd.
12.14 Kolltan Pharmaceuticals, Inc.
12.14.1 Company profile
12.14.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.14.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Kolltan Pharmaceuticals, Inc.
12.15 Natco Pharma Limited
12.15.1 Company profile
12.15.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
12.15.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Natco Pharma Limited
12.16 Nerviano Medical Sciences S.r.l.
12.17 Novartis AG
12.18 Omeros Corporation
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
13.1 Industry Chain of Gastrointestinal Stromal Tumor (GIST) Drug
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
14.1 Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.2 Raw Materials Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.3 Labor Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
14.4 Manufacturing Expenses Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
